Evaluation of the Application Effectiveness of the Autoverification System for Coagulation Test Reports

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600129311

Enrollment

Unknown

Registered

2026-08-03

Start date

2026-08-03

Completion date

Unknown

Last updated

2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

not involve

Interventions

Establishment of autoverification rules:None

Rule Validation Group:None

Eligibility

Sex/Gender

All

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients who underwent coagulation function testing using the ACL TOP 700 LAS fully automated coagulation analyzer from the Laboratory Department of Xinqiao Hospital between January 2024 and November 2025.

Exclusion criteria

Exclusion criteria: 1. Patients with severe hemolysis, lipid blood or clots in the specimen that make it undetectable; 2. Patients with abnormal results due to instrument malfunctions during the testing process; 3. Patients with repeated specimen testing (retaining only the first test result).

Design outcomes

Primary

Measure	Time frame
Passing rate, consistency rate, Specimen Turnaround Time (TAT);	—

Secondary

Measure	Time frame
routine coagulation;	—

Countries

China

Contacts

Public ContactMeng Fanfei

The Second Affiliated Hospital of the Army Medical University

mff001@163.com+86 23 68763363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026